巨噬细胞迁移抑制因子对脓毒症急性肾损伤的预测价值
本研究纳入入住ICU的脓毒症患者,按KDIGO指南诊断和分期脓毒症AKI,采集血样并记录临床资料。采用logistic回归筛选独立危险因素,绘制ROC曲线计算AUC,并用Cox回归分析血清MIF水平与脓毒症AKI死亡率的关系。结果显示入住ICU时血清MIF水平高者更易发生AKI,血清MIF预测脓毒症AKI的AUC为0.797;血清MIF水平越高,AKI越重、死亡率越高。作者认为血清MIF可能成为预测脓毒症AKI发生、发展及结局的生物标志物,但该结论尚需更有力的研究证实。
要点
- 入住ICU时血清MIF水平高的脓毒症患者更易发生AKI。
- 血清MIF预测脓毒症AKI的AUC为0.797,原文评价为良好预测指标。
- 血清MIF水平越高,对应AKI越严重、死亡率越高。
- 脓毒症AKI按KDIGO指南诊断和分期。
- 作者认为血清MIF可能作为预测脓毒症AKI发生、发展和结局的生物标志物,结论尚需更有力的研究证实。
适用人群与场景
- 纳入入住ICU的脓毒症患者。
诊断标准与关键阈值
- 采用KDIGO指南确认脓毒症AKI的诊断和分期。
研究设计与关键结果
- 研究纳入入住ICU的脓毒症患者,采集血样检测并以KDIGO指南诊断和分期脓毒症AKI,同时记录临床资料。
- 通过logistic回归分析筛选独立危险因素,绘制ROC曲线并计算AUC。
- 入住ICU时血清MIF水平高的患者更可能发生AKI,血清MIF预测脓毒症AKI的AUC为0.797。
- 血清MIF水平越高,对应AKI越严重、死亡率越高;采用Cox回归分析血清MIF水平与脓毒症AKI死亡率的关系。
证据类型、等级与局限
- 研究类型:纳入ICU脓毒症患者的研究,具体设计原文未明确写出。
- 作者结论:血清MIF可能作为预测脓毒症AKI发生、发展和结局的生物标志物,该结论尚需未来更有力的研究证实。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为血清MIF可能作为预测脓毒症AKI发生、发展和结局的生物标志物。
- 原文结论指出该结论尚需未来更有力的研究证实。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Septic acute kidney injury (AKI) is a common condition in ICU with poor outcomes. Septic AKI patients have a progressively decreased urine output and increased serum creatinine. However, urine volume and serum creatinine showed poor sensitivity to early diagnosis of septic AKI. Searching for potential biomarkers to early detect AKI is crucial in day-to-day clinical practice. Macrophage migration inhibitory factor (MIF), primarily released by renal tubular epithelial cells, vascular endothelial cells, and immune cells, was found to be closely associated with the inflammatory response in sepsis. MIF may be used as a biomarker of septic AKI indicating aggravation of systemic inflammatory response.
METHODS: Our study included sepsis patients admitted to the ICU. The KDIGO guideline was used to confirm the diagnosis and staging of septic AKI. Blood samples were collected and tested, as well as clinical data were recorded. Independent risk factors were selected via logistic regression analysis. By drawing the receiver operating characteristic (ROC) curves, the area under the ROC curves (AUC) was computed. The relationship between serum MIF level and mortality of septic AKI was analyzed using Cox regression analysis.
RESULTS: With high serum MIF level at ICU admission, the patients were more likely to develop AKI. The AUC of serum MIF (MIFAUC = 0.797) was found to be a good predictor of septic AKI. In addition, higher serum MIF levels corresponded to more severe AKI as well as a higher mortality rate.
CONCLUSIONS: Serum MIF might be a biomarker for predicting the occurrence, development, and outcomes of septic AKI. This conclusion will need to be confirmed by more robust investigations in the future.
参考来源
- Li T, Zhang J, Long M, et al. Macrophage Migration Inhibitory Factor Provides a Predictive Performance of Septic Acute Kidney Injury. Shock. 2022. PMID: 35234206. doi:10.1097/SHK.0000000000001918
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。